Mbx biosciences to participate in upcoming november investor conferences

Carmel, ind., oct. 28, 2024 (globe newswire) -- mbx biosciences, inc. (nasdaq: mbx), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today announced that its management team will participate in the following upcoming investor conferences:
MBX Ratings Summary
MBX Quant Ranking